Institut Cardiovasculaire Paris Sud Signs Purchase Agreement with Imricor

Karen BorresenNews

26 October 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in iCMR guided cardiac ablation products, is pleased to announce the Jaques Cartier Private Hospital’s Institut Cardiovasculaire Paris Sud (ICPS) has signed a purchase agreement with Imricor. The Company is working with the site to schedule installation, training, and first procedures.

Maastricht University Medical Center Signs Purchase Agreement with Imricor

Karen BorresenUncategorized

29 September 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided ablation products, is pleased to announce the Maastricht University Medical Centre (MUMC) in the Netherlands has signed a purchase agreement for Imricor’s consumable products.

Rhön Clinic Bad Neustadt Campus Signs Purchase Agreement with Imricor

Karen BorresenNews

28 September 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided ablation products, is pleased to announce the Rhön Clinic Bad Neustadt Campus in Bad Neustadt an der Saale, Germany has signed a purchase agreement with Imricor. The Company is working with the site to schedule installation, training, and first procedures.

Imricor Awarded NIH Contract

Karen BorresenNews

27 September 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided ablation products, is pleased to announce it was awarded a contract from the US National Insitutues of Health (NIH) to develop an MRI comptabile myocardial biopsy system. Under the agreement, Imricor will receive US$399,539 over the next 12 months to develop a prototype system of devices that biopsy the inner walls of the heart, while using MR imaging to guide the procedure.

Imricor Announces Sales Collaboration with Optoacoustics

Karen BorresenNews

12 August 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce a sales collaboration with Optoacoustics Ltd, the world leader in innovative, high performance optical communication solutions for magnetic resonance (MR) applications.

Imricor Announces First Sales Collaboration with Philips

Karen BorresenNews

4 August 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the worldwide leader in MRI-guided cardiac ablation products, is pleased to announce the first sales collaboration with Philips, a global leader in healthcare technology.

Imricor Signs Agreement with German Group Purchasing Organisation, Sana

imricordevUncategorized

Imricor Medical Systems, Inc. is pleased to announce that it has signed a Master Purchasing Agreement with Sana Einkauf & Logistik GmbH of Ismaning Germany (Sana). Sana is the largest Group Purchasing Organisation (GPO) in Germany, with 600 cooperating hospitals and medical institutions across Germany and Switzerland. Approximately 80 of these sites perform cardiac ablations and are therefore potential Imricor customers.